免疫功能障碍在肥胖相关癌症风险、进展和转移中的作用。
The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis.
机构信息
Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN, 47906, USA.
出版信息
Cell Mol Life Sci. 2021 Apr;78(7):3423-3442. doi: 10.1007/s00018-020-03752-z. Epub 2021 Jan 19.
Abstract
Obesity has been linked to an increased risk of and a worse prognosis for several types of cancer. A number of interrelated mediators contribute to obesity's pro-tumor effects, including chronic adipose inflammation and other perturbations of immune cell development and function. Here, we review studies examining the impact of obesity-induced immune dysfunction on cancer risk and progression. While the role of adipose tissue inflammation in obesity-associated cancer risk has been well characterized, the effects of obesity on immune cell infiltration and activity within the tumor microenvironment are not well studied. In this review, we aim to highlight the impact of both adipose-mediated inflammatory signaling and intratumoral immunosuppressive signaling in obesity-induced cancer risk, progression, and metastasis.
摘要
肥胖与多种类型癌症的风险增加和预后恶化有关。许多相互关联的介质促成了肥胖的促肿瘤作用，包括慢性脂肪组织炎症和免疫细胞发育和功能的其他改变。在这里，我们回顾了研究肥胖引起的免疫功能障碍对癌症风险和进展影响的研究。虽然脂肪组织炎症在肥胖相关癌症风险中的作用已经得到很好的描述，但肥胖对肿瘤微环境中免疫细胞浸润和活性的影响还没有得到很好的研究。在这篇综述中，我们旨在强调脂肪介导的炎症信号和肿瘤内免疫抑制信号在肥胖诱导的癌症风险、进展和转移中的影响。
相似文献
1
The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis.免疫功能障碍在肥胖相关癌症风险、进展和转移中的作用。
Cell Mol Life Sci. 2021 Apr;78(7):3423-3442. doi: 10.1007/s00018-020-03752-z. Epub 2021 Jan 19.
2
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review).肥胖相关的髓系来源抑制细胞对癌症风险和进展的影响（综述）。
Int J Oncol. 2024 Aug;65(2). doi: 10.3892/ijo.2024.5667. Epub 2024 Jun 28.
3
Obesity-Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy.肥胖相关的髓系免疫抑制细胞：癌症风险和免疫治疗反应的关键因素。
Obesity (Silver Spring). 2021 Jun;29(6):944-953. doi: 10.1002/oby.23108. Epub 2021 Feb 22.
4
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.驱动炎症肿瘤微环境、肿瘤异质性和转移进展的机制。
Semin Cancer Biol. 2017 Dec;47:185-195. doi: 10.1016/j.semcancer.2017.08.001. Epub 2017 Aug 3.
5
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.肥胖与癌症机制：肿瘤微环境与炎症
J Clin Oncol. 2016 Dec 10;34(35):4270-4276. doi: 10.1200/JCO.2016.67.4283. Epub 2016 Nov 7.
6
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy.肥胖在肿瘤学中的作用具有双重性，它既能促进癌症的发生，又能增强抗肿瘤免疫治疗。
J Biomed Sci. 2022 Feb 14;29(1):12. doi: 10.1186/s12929-022-00796-0.
7
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.肥胖调节癌症炎症和抗肿瘤免疫的机制。
Biochem Biophys Res Commun. 2024 Nov 12;733:150437. doi: 10.1016/j.bbrc.2024.150437. Epub 2024 Jul 23.
8
Adipose tissue macrophages: the inflammatory link between obesity and cancer?脂肪组织巨噬细胞：肥胖与癌症之间的炎症联系？
Expert Opin Ther Targets. 2015 Apr;19(4):527-38. doi: 10.1517/14728222.2014.991311. Epub 2014 Dec 4.
9
The Impact of the Adipose Organ Plasticity on Inflammation and Cancer Progression.脂肪组织可塑性对炎症和癌症进展的影响。
Cells. 2019 Jun 30;8(7):662. doi: 10.3390/cells8070662.
10
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.从炎症角度理解肥胖重塑乳腺肿瘤免疫微环境的机制
Cancer Biol Med. 2023 Mar 8;20(4):268-86. doi: 10.20892/j.issn.2095-3941.2022.0547.
引用本文的文献
1
The Role of Obesity in the Regulation of Immunosuppressive Cell Infiltration and Immunosurveillance in Cancers.肥胖在癌症中免疫抑制细胞浸润调节及免疫监视中的作用
Diseases. 2025 Aug 21;13(8):271. doi: 10.3390/diseases13080271.
2
Exploring molecular links between obesity and osteoporosis: insights from in-silico analysis and mannose supplementation.探索肥胖与骨质疏松症之间的分子联系：来自计算机模拟分析和甘露糖补充的见解。
Sci Rep. 2025 Aug 11;15(1):29384. doi: 10.1038/s41598-025-07294-x.
3
Integrative analysis of T cell-associated markers in Ewing sarcoma reveals prognostic signatures and immune dynamics.尤因肉瘤中T细胞相关标志物的综合分析揭示了预后特征和免疫动态。
Front Immunol. 2025 Jun 18;16:1586544. doi: 10.3389/fimmu.2025.1586544. eCollection 2025.
4
A Prognostic Nutritional Index-Based Nomogram to Predict Breast Cancer Metastasis: A Retrospective Cohort Validation.一种基于预后营养指数的列线图预测乳腺癌转移：一项回顾性队列验证研究
Breast Cancer (Dove Med Press). 2025 Jun 10;17:497-510. doi: 10.2147/BCTT.S523001. eCollection 2025.
5
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.结直肠癌中肠道微生物群与脂肪酸代谢之间的相互作用
Cell Death Discov. 2025 Feb 26;11(1):78. doi: 10.1038/s41420-025-02364-5.
6
Unveiling the link between chronic inflammation and cancer.揭示慢性炎症与癌症之间的联系。
Metabol Open. 2025 Jan 9;25:100347. doi: 10.1016/j.metop.2025.100347. eCollection 2025 Mar.
7
The General Principle of the Warburg Effect as a Possible Approach for Cancer Immunotherapy: The Regulatory Effect of Plant Extracts Could Change the Game.瓦伯格效应作为癌症免疫治疗可能途径的一般原理：植物提取物的调节作用可能会改变局面。
Molecules. 2025 Jan 18;30(2):393. doi: 10.3390/molecules30020393.
8
Health Benefits of Monk Fruit under Traditional Dietary Patterns: Perspective on Immunity and Gut Microbiota Modulatory Functions.传统饮食模式下罗汉果的健康益处：对免疫和肠道微生物群调节功能的见解
Plant Foods Hum Nutr. 2024 Dec 30;80(1):26. doi: 10.1007/s11130-024-01260-0.
9
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.原发性和转移性乳腺癌中的代谢重编程和治疗抵抗。
Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x.
10
Lipids in the tumor microenvironment: immune modulation and metastasis.肿瘤微环境中的脂质：免疫调节与转移
Front Oncol. 2024 Sep 26;14:1435480. doi: 10.3389/fonc.2024.1435480. eCollection 2024.
本文引用的文献
1
Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases.近期关于脂肪因子对炎性小体调节作用的研究进展：肥胖及代谢相关性疾病发病机制中的关键事件。
Arch Pharm Res. 2020 Oct;43(10):997-1016. doi: 10.1007/s12272-020-01274-7. Epub 2020 Oct 19.
2
The Confounders of Cancer Immunotherapy: Roles of Lifestyle, Metabolic Disorders and Sociological Factors.癌症免疫治疗的混杂因素：生活方式、代谢紊乱和社会学因素的作用
Cancers (Basel). 2020 Oct 15;12(10):2983. doi: 10.3390/cancers12102983.
3
Expected and paradoxical effects of obesity on cancer treatment response.肥胖对癌症治疗反应的预期和矛盾影响。
Rev Endocr Metab Disord. 2021 Dec;22(4):681-702. doi: 10.1007/s11154-020-09597-y. Epub 2020 Oct 6.
4
Obesity Has a Stronger Relationship with Colorectal Cancer in Postmenopausal Women than Premenopausal Women.与绝经前女性相比，肥胖与绝经后女性的结直肠癌关系更为密切。
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2277-2288. doi: 10.1158/1055-9965.EPI-20-0594. Epub 2020 Aug 31.
5
Obesity-induced inflammation and insulin resistance: A mini-review on T-cells.肥胖诱导的炎症与胰岛素抵抗：关于T细胞的小型综述
Metabol Open. 2019 Aug 10;3:100015. doi: 10.1016/j.metop.2019.100015. eCollection 2019 Sep.
6
Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.根据基线体重指数，早期乳腺癌患者辅助多西他赛化疗的获益差异。
J Clin Oncol. 2020 Sep 1;38(25):2883-2891. doi: 10.1200/JCO.19.01771. Epub 2020 Jul 2.
7
Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.成年人肥胖和重度肥胖的患病率：美国，2017-2018 年。
NCHS Data Brief. 2020 Feb(360):1-8.
8
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.超重和免疫相关不良反应对 PD-1 抗体免疫治疗癌症疗效的影响。
Oncoimmunology. 2020 Apr 16;9(1):1751548. doi: 10.1080/2162402X.2020.1751548. eCollection 2020.
9
Breast Adipocyte Co-culture Increases the Expression of Pro-angiogenic Factors in Macrophages.乳腺脂肪细胞共培养增加巨噬细胞中促血管生成因子的表达。
Front Oncol. 2020 Apr 7;10:454. doi: 10.3389/fonc.2020.00454. eCollection 2020.
10
Leptin acts on mesenchymal stem cells to promote chemoresistance in osteosarcoma cells.瘦素通过间充质干细胞作用促进骨肉瘤细胞的化疗耐药性。
Aging (Albany NY). 2020 Apr 14;12(7):6340-6351. doi: 10.18632/aging.103027.
Zotero 插件